the role of soft and text in treatment decision making for patients with breast cancer
Published 2 years ago • 159 plays • Length 3:50Download video MP4
Download video MP3
Similar videos
-
2:12
two trials, soft and text, investigating combination treatments for patients with breast cancer
-
3:04
12-year follow-up of soft and text trials
-
3:12
combination treatments for premenopausal breast cancer: endocrine therapy and ovarian suppression
-
1:43
evaluating endocrine therapy in pre-menopausal women with breast cancer
-
4:05
prescribing practices of endocrine therapy for premenopausal breast cancer patients in mexico
-
8:18
endocrine therapy in premenopausal women with hr breast cancer
-
3:11
ovarian function suppression in premenopausal women with breast cancer
-
41:53
guideline updates for extended endocrine therapy decision-making in hr , early-stage breast cancer
-
53:42
guideline updates for extended endocrine therapy decision-making in hr , early-stage breast cancer
-
24:33
session 9: adjuvant endocrine therapy for premenopausal women: risk stratification, type & duration
-
1:32
dr. o’shaughnessy on clinical implications of the text and soft trials in breast cancer
-
1:09
dr. rao on the soft trial in patients with premenopausal breast cancer
-
1:11
the mimosa trial and a novel prognostic factor in breast cancer
-
6:54
key clinical trials investigating immunotherapy in her2 and hr breast cancer
-
6:28
ovarian suppression in metastatic hr breast cancer
-
0:58
dr. francis on the benefits of ovarian suppression for younger women
-
1:13
dr. pagani discusses aromatase inhibitors for premenopausal women with breast cancer
-
2:47
adjuvant endocrine therapy in premenopausal breast cancer: 12-year results from soft
-
1:15
treating breast cancer in premenopausal women